candesartan has been researched along with Sleep Apnea Syndromes in 1 studies
candesartan: a nonpeptide angiotensin II receptor antagonist
candesartan : A benzimidazolecarboxylic acid that is 1H-benzimidazole-7-carboxylic acid substituted by an ethoxy group at position 2 and a ({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl) group at position 1. It is a angiotensin receptor antagonist used for the treatment of hypertension.
Sleep Apnea Syndromes: Disorders characterized by multiple cessations of respirations during sleep that induce partial arousals and interfere with the maintenance of sleep. Sleep apnea syndromes are divided into central (see SLEEP APNEA, CENTRAL), obstructive (see SLEEP APNEA, OBSTRUCTIVE), and mixed central-obstructive types.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Hypoxia caused by sleep apnea might be associated with an increased risk of cardiovascular events in subjects with metabolic syndrome." | 1.33 | Angiotensin-II receptor blocker exerts cardioprotection in diabetic rats exposed to hypoxia. ( Furuya, E; Hayashi, T; Inamoto, S; Kitaura, Y; Matsumura, Y; Mori, T; Nakano, D; Okuda, N; Sakai, A; Sohmiya, K; Tazawa, N; Yamashita, C, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inamoto, S | 1 |
| Hayashi, T | 1 |
| Tazawa, N | 1 |
| Mori, T | 1 |
| Yamashita, C | 1 |
| Nakano, D | 1 |
| Matsumura, Y | 1 |
| Okuda, N | 1 |
| Sohmiya, K | 1 |
| Sakai, A | 1 |
| Furuya, E | 1 |
| Kitaura, Y | 1 |
1 other study available for candesartan and Sleep Apnea Syndromes
| Article | Year |
|---|---|
Angiotensin-II receptor blocker exerts cardioprotection in diabetic rats exposed to hypoxia.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure | 2006 |